MedPath

MK-8507

Generic Name
MK-8507

A Study of MK-8507 and Islatravir (MK-8591) in Healthy Adult Participants (MK-8507-016)

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2024-09-30
Last Posted Date
2024-09-30
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
36
Registration Number
NCT06619678
Locations
🇺🇸

Celerion (Site 0001), Lincoln, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath